Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human 5HT2A Receptor ELISA Kit (AC3547)
Cat.#: ASET-2136
Specifications
Description Human 5HT2A Receptor ELISA Kit allows for the in vitro quantitative determination of human 5HT2A Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2231 Human Dystrophin ELISA Kit (AC3642) Quantitative inquiry ASET-1775 Mouse ProDynorphin ELISA Kit (AC3186) Quantitative inquiry ASET-2494 Rat Inhibin beta B ELISA Kit (AC3905) Quantitative inquiry ASET-1552 Human UNC5C ELISA Kit (AC2963) Quantitative inquiry ASET-2031 Human Plexin A2 ELISA Kit (AC3442) Quantitative inquiry ASET-2188 Human ProSAAS ELISA Kit (AC3599) Quantitative inquiry ASET-1803 Human CPE ELISA Kit (AC3214) Quantitative inquiry ASET-1616 Human 5HT2A Receptor ELISA Kit (AC3027) Quantitative inquiry ASET-1537 Rat EAAT3 ELISA Kit (AC2948) Quantitative inquiry ASET-1431 Human Kallikrein 6 ELISA Kit (AC2842) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket